Financial Performance - Medtronic reported quarterly earnings of 1.39pershare,exceedingtheZacksConsensusEstimateof1.36 per share, and up from 1.30pershareayearago,representinganearningssurpriseof2.218.29 billion for the quarter ended January 2025, slightly missing the Zacks Consensus Estimate by 0.43%, but up from 8.09billionyear−over−year[2]−Overthelastfourquarters,MedtronichassurpassedconsensusEPSestimatesfourtimesandtoppedconsensusrevenueestimatesthreetimes[2]StockPerformance−Medtronicshareshaveincreasedapproximately16.21.61 on revenues of 8.85billion,andforthecurrentfiscalyear,itis5.45 on revenues of $33.56 billion [7] - The outlook for the Medical - Products industry is favorable, ranking in the top 31% of over 250 Zacks industries, suggesting that stocks in this sector are likely to outperform those in the bottom 50% [8]